| Titre : | Dietary saturated fat and heart disease: a narrative review (2020) |
| Auteurs : | Jeffery L. Heileson |
| Type de document : | Article |
| Dans : | Nutrition reviews (Vol. 78, n° 6, June 2020) |
| Article en page(s) : | p. 474–485 |
| Note générale : | doi:10.1093/nutrit/nuz091 |
| Langues: | Anglais |
| Descripteurs : |
HE Vinci Acides gras ; Acides gras trans ; Cardiopathies ; Cholestérol ; Méta-analyse |
| Résumé : | The American Heart Association (AHA) recently published a meta-analysis that confirmed their 60-year-old recommendation to limit saturated fat (SFA, saturated fatty acid) and replace it with polyunsaturated fat to reduce the risk of heart disease based on the strength of 4 Core Trials. To assess the evidence for this recommendation, meta-analyses on the effect of SFA consumption on heart disease outcomes were reviewed. Nineteen meta-analyses addressing this topic were identified: 9 observational studies and 10 randomized controlled trials. Meta-analyses of observational studies found no association between SFA intake and heart disease, while meta-analyses of randomized controlled trials were inconsistent but tended to show a lack of an association. The inconsistency seems to have been mediated by the differing clinical trials included. For example, the AHA meta-analysis only included 4 trials (the Core Trials), and those trials contained design and methodological flaws and did not meet all the predefined inclusion criteria. The AHA stance regarding the strength of the evidence for the recommendation to limit SFAs for heart disease prevention may be overstated and in need of reevaluation. |
| Disponible en ligne : | Oui |
| En ligne : | https://login.ezproxy.vinci.be/login?url=https://academic.oup.com/nutritionreviews/article/78/6/474/5678770 |
Exemplaires (1)
| Cote | Support | Localisation | Section | Disponibilité |
|---|---|---|---|---|
| Nutrition reviews. Vol. 78, n° 6 (June 2020) | Périodique papier | Woluwe | Espace revues | Consultation sur place uniquement Exclu du prêt |
